These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H. J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078 [Abstract] [Full Text] [Related]
13. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Lindström S, Wiklund F, Adami HO, Bälter KA, Adolfsson J, Grönberg H. Cancer Res; 2006 Nov 15; 66(22):11077-83. PubMed ID: 17108148 [Abstract] [Full Text] [Related]
14. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer]. Xu DK, Zhang XM, Zhao P, Cai JC, Zhao D, Tan W, Guo YL, Lin DX. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1961-5. PubMed ID: 19062735 [Abstract] [Full Text] [Related]
15. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer]. Zhang XM, Miao XP, Tan W, Sun T, Guo YL, Zhao D, Lin DX. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr 22; 28(2):119-23. PubMed ID: 16733888 [Abstract] [Full Text] [Related]
17. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB. Cancer Res; 2001 Dec 15; 61(24):8617-23. PubMed ID: 11751373 [Abstract] [Full Text] [Related]
18. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J. Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):616-9. PubMed ID: 15767339 [Abstract] [Full Text] [Related]
19. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Lindmark F, Zheng SL, Wiklund F, Bensen J, Bälter KA, Chang B, Hedelin M, Clark J, Stattin P, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J. J Natl Cancer Inst; 2004 Aug 18; 96(16):1248-54. PubMed ID: 15316060 [Abstract] [Full Text] [Related]
20. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D. Cancer Res; 2004 Oct 15; 64(20):7622-8. PubMed ID: 15492291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]